Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Quidel’s Stock Soars In Response To Avian Flu Threat, Gains 22.7% In October

This article was originally published in The Gray Sheet

Executive Summary

Anticipation of the flu season and the threat of a global pandemic fueled Wall Street's attention on influenza test manufacturer Quidel in October

You may also be interested in...



NuVasive Boosts Artificial Disc Development, Stock; OTC Index Rises 15%

NuVasive will use profits gained from a series of 510(k)-cleared spinal devices to fuel artificial disc and nucleus replacement development in 2006

NuVasive Boosts Artificial Disc Development, Stock; OTC Index Rises 15%

NuVasive will use profits gained from a series of 510(k)-cleared spinal devices to fuel artificial disc and nucleus replacement development in 2006

Medical Services Int’l Poised To Be First Marketer Of Bird Flu Test In China

A Canadian diagnostic firm that specializes in developing cost-effective tests for third world countries says it will be the first-to-market in China with a rapid diagnostic test for avian influenza Type A virus, or "bird flu.

Related Content

UsernamePublicRestriction

Register

MT022905

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel